$5.50 Million Series Seed

In August 2024, SYLKE® raised a $5.5 million Series Seed at a $50 million pre-money valuation.

$10.03 Million Series A

In March 2025, SYLKE® raised a $10.03 million Series A at a $150 million pre-money valuation.

$5.50 Million Series Seed

In August 2024, SYLKE® raised a $5.5 million Series Seed at a $50 million pre-money valuation.

Latest Articles

View Blog

$10.03 Million Series A

In March 2025, SYLKE® raised a $10.03 million Series A at a $150 million pre-money valuation.
$5.50 Million Series Seed

In August 2024, SYLKE® raised a $5.5 million Series Seed at a $50 million pre-money valuation.

SYLKE® Adhesive Wound Closure is an FDA Class I, 510(k)-exempt medical device.
Products may not be available in all countries; availability is subject to local regulatory clearance.
© 2025 Sylke, Inc. All rights reserved. MM-24-006 V5

My Account

SYLKE® Adhesive Wound Closure

SYLKE® Patient Discharge Sheet

SYLKE MD® Antimicrobial Longline Bra

SYLKE MD® Antimicrobial Boyshort

$5.50 Million Series Seed

$10.03 Million Series A

$5.50 Million Series Seed

Latest Articles

$10.03 Million Series A

$5.50 Million Series Seed

Cart (0)